thiazolidines has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Liou, LC; Luo, Y; Ren, Q; Wang, S; Witt, SN; Xu, B; Zhang, Z | 1 |
| Ishikawa, Y; Nakano, M; Nishizawa, Y; Takeuchi, M; Wada, R; Yagihashi, N; Yagihashi, S; Yasumura, K | 1 |
2 other study(ies) available for thiazolidines and Nerve Degeneration
| Article | Year |
|---|---|
α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2.
Topics: alpha-Synuclein; Analysis of Variance; beta-Galactosidase; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Humans; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Nerve Degeneration; Parkinson Disease; Protein Serine-Threonine Kinases; Signal Transduction; Thiazolidines; Yeasts | 2012 |
Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glycation End Products, Advanced; Male; Nerve Degeneration; Neural Conduction; Rats; Rats, Wistar; Thiadiazoles; Thiazolidines | 2001 |